Litigation Details for Zachary Silbersher v. Allergan, Inc. (9th Cir. 2023)
✉ Email this page to a colleague
Zachary Silbersher v. Allergan, Inc. (9th Cir. 2023)
| Docket | ⤷ Try a Trial | Date Filed | 2023-04-25 |
| Court | Court of Appeals for the Ninth Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 8,039,009 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Zachary Silbersher v. Allergan, Inc.
The small molecule drugs covered by the patent cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Zachary Silbersher v. Allergan, Inc. (9th Cir. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-01-29 | 24 | subsidiary) misled the PTO while prosecuting the 8,039,009 Patent, which claims a “method of treating Alzheimer… U.S. Patent & Trademark Office, browsed the agency’s official records of decade-old patent prosecution…allegations center on the so-called “Went Patents,” a series of 11 patents named after Adamas’s then-CEO and …attention to the ’553 Patent, which allegedly would have foreclosed the ’009 Patent on obviousness grounds…submitted the ’553 Patent at “an earlier phase of the prosecution” of the ’009 Patent, but he claims that | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
